Current issue
Archive
Manuscripts accepted
About the Journal
Editorial office
Editorial board
Section Editors
Abstracting and indexing
Subscription
Contact
Ethical standards and procedures
Most read articles
Instructions for authors
Article Processing Charge (APC)
Regulations of paying article processing charge (APC)
HEART FAILURE / BASIC RESEARCH
Tangeretin prevents cardiac failure induced by reperfusion/ischaemia by inhibiting apoptosis, endoplasmic reticulum stress, and JNK/ERK pathway
1
Department of Anaesthesiology, Xiangya Hospital, Central South University, Changsha, Hunan, China
Submission date: 2020-01-14
Final revision date: 2020-06-02
Acceptance date: 2020-06-04
Online publication date: 2020-07-08
Publication date: 2026-04-30
Corresponding author
Jian Wang
Department of Anaesthesiology Xiangya Hospital Central South University 410008 Changsha Hunan, China Phone/fax: +86 0731 89757413
Department of Anaesthesiology Xiangya Hospital Central South University 410008 Changsha Hunan, China Phone/fax: +86 0731 89757413
Arch Med Sci 2026;22(2):983-990
KEYWORDS
TOPICS
ABSTRACT
Introduction:
Cardiac diseases constitute the leading cause of human mortality across the globe. The study was conducted to examine the cardiac preventive effects of tangeretin on H9c2 cardiomyocytes.
Material and methods:
Ischaemia/reperfusion was induced in H9c2 cardiomyocytes through anoxygenic conditions. CCK8 was used for estimation of the viability of cardiomyocytes. SOD, CAT, and GSH were determined by biochemical assays. Apoptosis was assessed through DAPI, EdU, and Annexin V/PI staining assays. ROS levels were determined by flow cytometry. The mRNA expression was determined by qRT-PCR, and protein expression was determined by western blotting.
Results:
The results showed that tangeretin treatment enhanced the proliferation of ischaemic cardiomyocytes in a time-dependent fashion. The EDU and DAPI staining assays showed that ischaemic cardiomyocytes exhibited lower proliferation rates and higher apoptosis. However, treatment with tangeretin exerted protective effects by inhibiting apoptosis in ischaemic cardiomyocytes. Additionally, annexin V/PI assay showed that tangeretin treatment reduced the percentage of the apoptotic cells in the ischaemic cardiomyocytes. The expression of Bax and caspase-3 were decreased and that of Bcl-2 was increased in ischaemic cardiomyocytes upon tangeretin treatment. The low cytometric analysis showed that tangeretin suppressed the ROS levels in ischaemic cardiomyocytes by increasing the expression of SOD, CAT, and GSH. Finally, tangeretin blocked the JNK/ERK signalling pathway in the ischaemic H9c2 cardiomyocytes.
Conclusions:
This study establishes the cardio-protective role of tangeretin and may pave the way for conducting more such studies in the future.
Cardiac diseases constitute the leading cause of human mortality across the globe. The study was conducted to examine the cardiac preventive effects of tangeretin on H9c2 cardiomyocytes.
Material and methods:
Ischaemia/reperfusion was induced in H9c2 cardiomyocytes through anoxygenic conditions. CCK8 was used for estimation of the viability of cardiomyocytes. SOD, CAT, and GSH were determined by biochemical assays. Apoptosis was assessed through DAPI, EdU, and Annexin V/PI staining assays. ROS levels were determined by flow cytometry. The mRNA expression was determined by qRT-PCR, and protein expression was determined by western blotting.
Results:
The results showed that tangeretin treatment enhanced the proliferation of ischaemic cardiomyocytes in a time-dependent fashion. The EDU and DAPI staining assays showed that ischaemic cardiomyocytes exhibited lower proliferation rates and higher apoptosis. However, treatment with tangeretin exerted protective effects by inhibiting apoptosis in ischaemic cardiomyocytes. Additionally, annexin V/PI assay showed that tangeretin treatment reduced the percentage of the apoptotic cells in the ischaemic cardiomyocytes. The expression of Bax and caspase-3 were decreased and that of Bcl-2 was increased in ischaemic cardiomyocytes upon tangeretin treatment. The low cytometric analysis showed that tangeretin suppressed the ROS levels in ischaemic cardiomyocytes by increasing the expression of SOD, CAT, and GSH. Finally, tangeretin blocked the JNK/ERK signalling pathway in the ischaemic H9c2 cardiomyocytes.
Conclusions:
This study establishes the cardio-protective role of tangeretin and may pave the way for conducting more such studies in the future.
REFERENCES (24)
1.
Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 2006; 3: e442.
2.
Moran AE, Tzong KY, Forouzanfar MH, et al. Variations in ischemic heart disease burden by age, country, and income: the Global Burden of Diseases, Injuries, and Risk Factors 2010 study. Global Heart 2014; 9: 91-9.
3.
Nordlie MA, Wold LE, Kloner RA. Genetic contributors toward increased risk for ischemic heart disease. J Mol Cell Cardiol 2005; 39: 667-79.
4.
Bialik S, Geenen DL, Sasson IE, et al. Myocyte apoptosis during acute myocardial infarction in the mouse localizes to hypoxic regions but occurs independently of p53. J Clin Investig 1997; 100: 1363-72.
5.
Hayashi T, Saito A, Okuno S, Ferrand-Drake M, Chan PH. Induction of GRP78 by ischemic preconditioning reduces endoplasmic reticulum stress and prevents delayed neuronal cell death. J Cereb Blood Flow Metabol 2003; 23: 949-61.
6.
Liu ZW, Zhu HT, Chen KL, et al. Protein kinase RNA-like endoplasmic reticulum kinase (PERK) signaling pathway plays a major role in reactive oxygen species (ROS)-mediated endoplasmic reticulum stress-induced apoptosis in diabetic cardiomyopathy. Cardiovasc Diabetol 2013; 12: 158.
7.
Varela Carver A, Parker H, Kleinert C, Rimoldi O. Adverse effects of cigarette smoke and induction of oxidative stress in cardiomyocytes and vascular endothelium. Curr Pharmaceutical Design 2010; 16: 2551-8.
8.
Natural antioxidants: chemistry, health effects, and applications. Shahidi F (ed.) The American Oil Chemists Society 1997.
9.
Sun J, Tan BK, Huang SH, Whiteman M, Zhu YZ. Effects of natural products on ischemic heart diseases and cardiovascular system. Acta Pharmacologica Sinica 2002; 23: 1142-51.
10.
Russo M, Spagnuolo C, Tedesco I, Bilotto S, Russo GL. The flavonoid quercetin in disease prevention and therapy: facts and fancies. Biochem Pharmacol 2012; 83: 6-15.
11.
Havsteen B. Flavonoids, a class of natural products of high pharmacological potency. Biochem Pharmacol 1983; 32: 1141-8.
12.
Kumar S, Pandey AK. Chemistry and biological activities of flavonoids: an overview. Sci World J 2013; 2013: 162750.
13.
Dudzińska D, Boncler M, Watala C. The cardioprotective power of leaves. Arch Med Sci 2015; 11: 819-39.
14.
Martindale JL, Holbrook NJ. Cellular response to oxidative stress: signaling for suicide and survival. J Cell Physiol 2002; 192: 1-15.
15.
Ferreiro E, Baldeiras I, Ferreira IL, et al. Mitochondrial-and endoplasmic reticulum-associated oxidative stress in Alzheimer’s disease: from pathogenesis to biomarkers. Int J Cell Biol 2012; 2012: 735206.
16.
Olivetti G, Abbi R, Quaini F, et al. Apoptosis in the failing human heart. N Engl J Med 1997; 336: 1131-41.
17.
Cuadrado I, Fernández-Velasco M, Boscá L, de Las Heras B. Labdane diterpenes protect against anoxia/reperfusion injury in cardiomyocytes: involvement of AKT activation. Cell Death Dis 2011; 2: e229.
18.
Dragovich T, Rudin CM, Thompson CB. Signal transduction pathways that regulate cell survival and cell death. Oncogene 1998; 17: 3207-13.
19.
O’Reilly LA, Huang DC, Strasser A. The cell death inhibitor Bcl‐2 and its homologues influence control of cell cycle entry. EMBO J 1996; 15: 6979-90.
20.
Li C, Wang T, Zhang C, Xuan J, Su C, Wang Y. Quercetin attenuates cardiomyocyte apoptosis via inhibition of JNK and p38 mitogen-activated protein kinase signaling pathways. Gene 2016; 577: 275-80.
21.
Lee JH, Won YS, Park KH, et al. Celastrol inhibits growth and induces apoptotic cell death in melanoma cells via the activation ROS-dependent mitochondrial pathway and the suppression of PI3K/AKT signaling. Apoptosis 2012; 17: 1275-86.
22.
Brantley-Finley C, Lyle CS, Du L, et al. The JNK, ERK and p53 pathways play distinct roles in apoptosis mediated by the antitumor agents vinblastine, doxorubicin, and etoposide. Biochem Pharmacol 2003; 66: 459-69.
23.
Chuang SM, Liou GY, Yang JL. Activation of JNK, p38 and ERK mitogen-activated protein kinases by chromium (VI) is mediated through oxidative stress but does not affect cytotoxicity. Carcinogenesis 2000; 21: 1491-500.
24.
Huang F, Liu Q, Xie S, et al. Cypermethrin induces macrophages death through cell cycle arrest and oxidative stress-mediated JNK/ERK signaling regulated apoptosis. Int J Mol Sci 2016; 17: 885.
Share
RELATED ARTICLE
| eISSN: | 1896-9151 |
| ISSN: | 1734-1922 |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
